Summary
Manuka honey is a unique honey derived from the nectar of the manuka tea tree, which grows mainly in remote, pristine native forests of New Zealand and Australia. The leaves and bark of the tree have been used by Māori as a natural remedy with analgesic, antipyretic, and antiseptic properties. Compared with regular honey, manuka honey contains phenol and has stable antibacterial activity that is not easily broken down by the body.
It effectively improves gastrointestinal disorders (such as gastroenteritis, indigestion, diarrhoea, duodenal ulcers) and skin wounds. Its therapeutic benefits have been clinically proven in New Zealand and Australia, and it is the only honey ingredient approved for the pharmaceutical market in the United States. Known as the ‘cream of the crop’, manuka honey has broad market prospects.
Key companies include New Zealand-based Comvita, Manuka Health, Arataki Honey, Watson & Son, Streamland, and Pure Honey New Zealand.
Commentary
As an iconic New Zealand product, manuka honey’s unique antibacterial and therapeutic properties have gained global recognition, particularly with its pharmaceutical approval in the US market, opening the door to high-end medical applications for New Zealand’s honey industry. For local small and medium-sized enterprises (SMEs), this represents significant commercial opportunities: on one hand, they can leverage manuka honey’s ‘superfood’ positioning to expand into the health supplement and functional food markets; on the other, with rising global demand for natural antibacterial products, applications in skincare and oral care are worth exploring. However, competition is intensifying, with Australia also promoting its manuka honey, and emerging markets like China imposing strict requirements on honey quality and traceability.
SMEs need to focus on brand building, quality certification (e.g., UMF rating), and supply chain transparency to build consumer trust. Additionally, US-China trade tensions may affect Chinese consumers’ purchasing power for imported honey, but the upgraded free trade agreement between New Zealand and China has lowered tariffs, facilitating exports. Businesses are advised to target Chinese e-commerce platforms and health food channels, while developing differentiated products such as manuka honey capsules or medical-grade dressings to enhance value.
Overall, the market outlook for manuka honey is positive, but success hinges on quality control and targeted marketing.
Keywords: Manuka honey, New Zealand, antibacterial, therapeutic benefits, market prospects, Comvita, Manuka Health, UMF, export, health supplements
Summary in Chinese | 摘要
麦卢卡蜂蜜是一种蜜源为麦卢卡茶树的特色蜂蜜，主要生长于新西兰和澳大利亚的偏远无污染原始森林。其树叶和树皮被毛利人用作天然草药，具有镇痛、解热、消毒等功效。与普通蜂蜜相比，麦卢卡蜂蜜含有苯酚，抗菌成分活性稳定，不易被人体分解，能有效改善胃肠疾病（如肠胃炎、消化不良、腹泻、十二指肠溃疡）和皮肤创伤。
其治疗功效在新西兰和澳大利亚得到临床证实，在美国是唯一准入药品市场的蜂蜜添加成分。麦卢卡蜂蜜被誉为“蜜中极品”，市场前景广阔。主要企业包括新西兰本土的Comvita康维他、Manuka Health蜜纽康、Arataki Honey艾瑞塔奇、Watson & Son沃森、Streamland新溪岛和Pure Honey New Zealand等。
Commentary in Chinese | 评论
麦卢卡蜂蜜作为新西兰标志性产品，其独特的抗菌和治疗功效已获得全球认可，尤其在美国市场获得药品准入资格，这为新西兰蜂蜜产业打开了高端医疗应用的大门。对于新西兰中小企业主而言，这意味着巨大的商业机会：一方面，可以借助麦卢卡蜂蜜的“超级食品”定位，拓展保健品和功能性食品市场；另一方面，随着全球消费者对天然抗菌产品的需求上升，麦卢卡蜂蜜在护肤品、口腔护理等领域的应用也值得探索。然而，市场竞争日益激烈，澳大利亚也在推广其麦卢卡蜂蜜，且中国等新兴市场对蜂蜜品质和溯源要求严格。
中小企业需注重品牌建设、质量认证（如UMF评级）和供应链透明化，以建立消费者信任。此外，中美贸易摩擦可能影响中国消费者对进口蜂蜜的购买力，但新西兰与中国签订的自贸协定升级版降低了关税，为出口提供了便利。建议企业关注中国电商平台和健康食品渠道，同时开发差异化产品，如麦卢卡蜂蜜胶囊或医疗级敷料，以提升附加值。
总体来看，麦卢卡蜂蜜市场前景乐观，但成功关键在于品质把控和精准营销。
关键词: 麦卢卡蜂蜜, 新西兰, 抗菌, 治疗功效, 市场前景, 康维他, 蜜纽康, UMF, 出口, 保健品
Source: NetEase
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.
免责声明：本文基于公开信息编译，仅供一般性参考。文中分析与评论为编辑观点。MiDeer Observer 不对所提供信息的准确性或完整性作出保证。读者在依赖本文内容前，应寻求独立专业意见，或联系我们获取更多信息。